Activating mutations in MEK1 enhance homodimerization and promote tumorigenesis
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Activating mutations in MEK1 enhance homodimerization and promote tumorigenesis
Authors
Keywords
-
Journal
Science Signaling
Volume 11, Issue 554, Pages eaar6795
Publisher
American Association for the Advancement of Science (AAAS)
Online
2018-10-31
DOI
10.1126/scisignal.aar6795
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MEK drives BRAF activation through allosteric control of KSR proteins
- (2018) Hugo Lavoie et al. NATURE
- The dimer-dependent catalytic activity of RAF family kinases is revealed through characterizing their oncogenic mutants
- (2018) Jimin Yuan et al. ONCOGENE
- Activation Mechanism of Oncogenic Deletion Mutations in BRAF, EGFR, and HER2
- (2016) Scott A. Foster et al. CANCER CELL
- Oncogenic BRAF Deletions That Function as Homodimers and Are Sensitive to Inhibition by RAF Dimer Inhibitor LY3009120
- (2016) S.-H. Chen et al. Cancer Discovery
- Alike but Different: RAF Paralogs and Their Signaling Outputs
- (2015) Enrico Desideri et al. CELL
- MAP2K1andMAP3K1mutations in langerhans cell histiocytosis
- (2015) David S. Nelson et al. GENES CHROMOSOMES & CANCER
- Extreme Outlier Analysis Identifies Occult Mitogen-Activated Protein Kinase Pathway Mutations in Patients With Low-Grade Serous Ovarian Cancer
- (2015) Rachel N. Grisham et al. JOURNAL OF CLINICAL ONCOLOGY
- The Tetrahymena telomerase p75–p45–p19 subcomplex is a unique CST complex
- (2015) Bingbing Wan et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Grb2 monomer–dimer equilibrium determines normal versus oncogenic function
- (2015) Zamal Ahmed et al. Nature Communications
- Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms
- (2015) E. L. Diamond et al. Cancer Discovery
- The Tetrahymena telomerase p75–p45–p19 subcomplex is a unique CST complex
- (2015) Bingbing Wan et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- High prevalence of somatic MAP2K1 mutations in BRAF V600E-negative Langerhans cell histiocytosis
- (2014) N. A. Brown et al. BLOOD
- Mutually exclusive recurrent somatic mutations in MAP2K1 and BRAF support a central role for ERK activation in LCH pathogenesis
- (2014) R. Chakraborty et al. BLOOD
- Structure of the BRAF-MEK Complex Reveals a Kinase Activity Independent Role for BRAF in MAPK Signaling
- (2014) Jacob R. Haling et al. CANCER CELL
- Disruption of CRAF-Mediated MEK Activation Is Required for Effective MEK Inhibition in KRAS Mutant Tumors
- (2014) Piro Lito et al. CANCER CELL
- “RAF” neighborhood: Protein-protein interaction in the Raf/Mek/Erk pathway
- (2014) Botond Cseh et al. FEBS LETTERS
- Kinase Regulation by Hydrophobic Spine Assembly in Cancer
- (2014) Jiancheng Hu et al. MOLECULAR AND CELLULAR BIOLOGY
- Kinases and Pseudokinases: Lessons from RAF
- (2014) A. S. Shaw et al. MOLECULAR AND CELLULAR BIOLOGY
- Crystal structure of a BRAF kinase domain monomer explains basis for allosteric regulation
- (2014) Neroshan Thevakumaran et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Calmodulin and PI(3,4,5)P3 cooperatively bind to the Itk pleckstrin homology domain to promote efficient calcium signaling and IL-17A production
- (2014) X. Wang et al. Science Signaling
- Oncogene Mimicry as a Mechanism of Primary Resistance to BRAF Inhibitors
- (2014) Martin L. Sos et al. Cell Reports
- Pseudokinases from a structural perspective
- (2013) Susan S. Taylor et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Allosteric Activation of Functionally Asymmetric RAF Kinase Dimers
- (2013) Jiancheng Hu et al. CELL
- Mechanism of MEK inhibition determines efficacy in mutant KRAS- versus BRAF-driven cancers
- (2013) Georgia Hatzivassiliou et al. NATURE
- High prevalence of MAP2K1 mutations in variant and IGHV4-34–expressing hairy-cell leukemias
- (2013) Joshua J Waterfall et al. NATURE GENETICS
- The Salmonella Kinase SteC Targets the MAP Kinase MEK to Regulate the Host Actin Cytoskeleton
- (2012) Charlotte Odendall et al. Cell Host & Microbe
- Distinct requirement for an intact dimer interface in wild-type, V600E and kinase-dead B-Raf signalling
- (2012) Michael Röring et al. EMBO JOURNAL
- MEK1/2 dual-specificity protein kinases: Structure and regulation
- (2011) Robert Roskoski BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E)
- (2011) Poulikos I. Poulikakos et al. NATURE
- Mutation that blocks ATP binding creates a pseudokinase stabilizing the scaffolding function of kinase suppressor of Ras, CRAF and BRAF
- (2011) J. Hu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Protein kinases: evolution of dynamic regulatory proteins
- (2010) Susan S. Taylor et al. TRENDS IN BIOCHEMICAL SCIENCES
- Crystal Structures of MEK1 Binary and Ternary Complexes with Nucleotides and Inhibitors
- (2009) Thierry O. Fischmann et al. BIOCHEMISTRY
- A Mek1–Mek2 heterodimer determines the strength and duration of the Erk signal
- (2009) Federica Catalanotti et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Lsc activity is controlled by oligomerization and regulates integrin adhesion
- (2007) Jiancheng Hu et al. MOLECULAR IMMUNOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started